Title:
TREATMENT MATERIAL
Document Type and Number:
WIPO Patent Application WO/2022/244551
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a treatment material used for the treatment of a disease a symptom of which is mitigated or treated through reduction of the phosphorus concentration in blood. The treatment material according to the present invention is to be used for the treatment of a disease a symptom of which is mitigated or treated through reduction of the phosphorus concentration in blood, and has a water-insoluble carrier and at least one adsorption group selected from the group consisting of a phosphate group, a phosphonate group, a phosphinate group, an amino group, a carboxy group, and a thiol group. The adsorption group is bound to the water-insoluble carrier via a linker group. The treatment material, which is to be used for the treatment of a disease a symptom of which is mitigated or treated through reduction of the phosphorus concentration in blood, is characterized by being used so as to cause calciprotein particles in blood, which had undergone a dialysis treatment, to be adsorbed by the adsorption group by having said blood to pass through the treatment material, or is characterized by being used so as to cause blood having passed therethrough to undergo a dialysis treatment.
Inventors:
FUJITA YUTA (JP)
KUROO MAKOTO (JP)
KUROO MAKOTO (JP)
Application Number:
PCT/JP2022/017596
Publication Date:
November 24, 2022
Filing Date:
April 12, 2022
Export Citation:
Assignee:
KANEKA CORP (JP)
BROAD BEAN SCIENCE CO LTD (JP)
BROAD BEAN SCIENCE CO LTD (JP)
International Classes:
A61P3/00; A61K35/14; A61M1/36; A61P5/22; A61P7/00; A61P7/08; A61P9/00; A61P11/00; A61P17/00; A61P17/02; A61P17/04; A61P19/08; A61P21/00; A61P25/28; B01J20/22
Domestic Patent References:
| WO2018025809A1 | 2018-02-08 |
Attorney, Agent or Firm:
USFI PATENT ATTORNEYS INTERNATIONAL OFFICE (JP)
Download PDF: